Skip to main content
SpringerLink
Log in

Erythropoiesis and serum sVCAM-1 levels in adults with sickle cell disease

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Sickle cell patients are characterized by stress erythropoiesis involving cytokines, growth factors, and adhesion molecules. We set out to determine whether serum soluble vascular cell adhesion molecule-1 (sVCAM-1) levels, which are inversely related to red blood cell counts in sickle cell disease (SCD), reflect erythropoietic activity in adult HbSS patients. Serum levels of sVCAM-1 were compared to erythropoietin (EPO), granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and soluble transferrin receptor (sTfR) levels in 29 adults with HbSS, and their respective levels were also compared to 29 race- and age-matched HbAA controls. EPO and sTfR levels were increased as compared to healthy controls, whereas IL-3 and GM-CSF were not. No significant correlation of sVCAM-1 levels could be detected with any of the measured erythropoietic markers. Patients, but not controls, with detectable IL-3 levels had lower sTfR and GM-CSF levels as compared to patients with undetectable IL-3 levels. Even though a link of sVCAM-1 to erythropoiesis could not be established, it cannot be ruled out that sVCAM-1 levels reflect the release of young red blood cells into the circulation. IL-3 and GM-CSF levels suggest that different rates of erythropoiesis may be characterized by specific cytokine profiles in SCD. Further research should focus on the potential cytokines and adhesion molecules involved in sickle cell erythropoiesis, as this may increase our understanding of sickle cell complications and may provide us with potential markers for risk assessment in sickle cell disease as well.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1A–D.

Similar content being viewed by others

References

  1. Yi-Hsin Chan J, Watt SM (2000) Adhesion receptors on haematopoietic progenitor cells. Br J Haematol 112:541–557

    Google Scholar 

  2. Jacobsen K, Kravitz J, Kincade PW, Osmond DG (1996) Adhesion receptors on bone marrow stromal cells: in vivo expression of vascular cell adhesion molecule-1 by reticular cells and sinusoidal endothelium in normal and γ-irradiated mice. Blood 87:73–82

    CAS  PubMed  Google Scholar 

  3. Serjeant GR (2001) Sickle cell disease. Oxford Press, New York

  4. Duits AJ, Pieters RC, Saleh AW, van Rosmalen E, Katenberg H, Berend K, Rojer RA (1996) Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis. Clin Immunol Immunopathol 81:96–98

    Article  CAS  PubMed  Google Scholar 

  5. Schnog JB, De Vries C, Van der Dijs FPL, Muskiet FD, Muskiet FAJ, Duits AJ (1998) Enhanced sVCAM-1 levels in pediatric patients with sickle cell disease (abstract). West Indian Med J 47 [Suppl 2]:55a

  6. Saleh AW, Hillen HFP, Duits AJ (1999) Levels of endothelial, neutrophil and platelet specific factors in sickle cell anemia patients during hydroxyurea treatment. Acta Haematol 102:31–37

    Article  CAS  PubMed  Google Scholar 

  7. Croizat H, Nagel R (1999) Circulating cytokines response and the levels of erythropoiesis in sickle cell anemia. Am J Hematol 60:105–115

    Article  CAS  PubMed  Google Scholar 

  8. Schnog JB, Keli SO, Pieters RA, Rojer RA, Duits AJ (2000) Duffy phenotype does not influence sickle cell disease severity. Clin Immunol 96:264–268

    Article  CAS  PubMed  Google Scholar 

  9. Van der Dijs FPL, Van den Berg GA, Schermer JG, Muskiet FD, Landman H, Muskiet FAJ (1992) Screening cord blood for hemoglobinopathies and thalassemia by HPLC. Clin Chem 38:1864–1869

    PubMed  Google Scholar 

  10. Bondurant MC, Koury MJ (1999) Hematopoiesis. In: Lee GR, Lukens J, Greer JP, Rodgers GM, Paraskevas F, Foerster J (eds) Wintrobe's clinical hematology, 10th edn. Lippincott Williams & Wilkins, Philadelphia

  11. Dosquet C, Chen Y, Makke J, Miclea JM, Coudert MC, Marolleau JP, Fermand JP, Cottu P, Lotz JP, Benbunan M (2001) Cytokines and vascular cell adhesion molecule-1 in the blood of patients undergoing HPC mobilization. Transfusion 41:206–212

    Article  CAS  PubMed  Google Scholar 

  12. Lévesque JP, Taamatsu Y, Nilsson SK, Haylock DN, Simmons PJ (2001) Vascular cell adhesion molecule-1 (CD 106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilisation by granulocyte colony-stimulating factor. Blood 98:1289–1297

    Article  PubMed  Google Scholar 

  13. Gee BE, Platt OS (1995). Sickle reticulocytes adhere to VCAM-1. Blood 85:268–274

    CAS  PubMed  Google Scholar 

  14. Haider MZ, Raghupathy R, Azizieh F, Abdelsalam R, D'Souza TM, Adekile AD (2000) GM-CSF in sickle cell anemia patients with elevated HbF. Acta Haematol 102:140–143

    Article  CAS  PubMed  Google Scholar 

  15. Croizat H (1994) Circulating cytokines in sickle cell patients during steady state. Br J Haematol 87:592–597

    CAS  PubMed  Google Scholar 

  16. Stuart MJ, Yamaja Setty BN (1999) Sickle cell acute chest syndrome: pathogenesis and rationale for treatment. Blood 94:1555–1560

    CAS  PubMed  Google Scholar 

  17. Setty BNY, Stuart MJ (1996) Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood 88:2311–2320

    CAS  PubMed  Google Scholar 

  18. Pieters RC, Rojer RA, Saleh AW, Saleh AE, Duits AJ (1995) Molgramostim to treat SS-sickle cell leg ulcers. Lancet 345:528

    CAS  Google Scholar 

  19. Dale GL, Alberio L (1998) Is there a correlation between raised erythropoietin and thrombotic events in sickle-cell anaemia? Lancet 352:566–567

    Article  CAS  PubMed  Google Scholar 

  20. Lard LR, Mul FP, de Haas M, Roos D, Duits AJ (1999) Neutrophil activation in sickle cell disease. J Leukoc Biol 66:411–415

    CAS  PubMed  Google Scholar 

  21. Velders GA, Pruijt JF, Verzaal P, van Os R, van Kooyk Y, Figdor CG, de Kruijf EJ, Willemze R, Fibbe WE (2002) Enhancement of G-CSF-induced stem cell mobilization by antibodies against the beta 2 integrins LFA-1 and Mac-1. Blood 100:327–333

    Article  CAS  PubMed  Google Scholar 

  22. Miller ST, Sleeper LA, Pegelow CH, Enos LE, Wang WC, Weiner SJ, Wethers DL, Smith J, Kinney TR (2000) Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 342:83–89

    Article  CAS  PubMed  Google Scholar 

  23. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR (1991) Pain in sickle cell disease. Rates and risk factors. N Engl J Med 325:11–16

    PubMed  Google Scholar 

  24. Castro O, Brambilla DJ, Thorington B, Reindorf CA, Scott RB, Gillette P, Vera JC, Levy PS (1994) The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 84:643–649

    CAS  PubMed  Google Scholar 

  25. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330:1639–1644

    PubMed  Google Scholar 

  26. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 91:288–294

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Contract grant sponsor: the Netherlands Antilles Society for Higher Clinical Education (NASKHO). H. ten Cate is an established investigator of the Netherlands Heart Foundation.

Author information

Authors and Affiliations

  1. Red Cross Bloodbank Curaçao, , Curaçao, Netherlands Antilles

    A. J. Duits, T. van Endt & J. B. Schnog

  2. Department of Internal Medicine, St. Elisabeth Hospital, Curaçao, Netherlands Antilles

    A. J. Duits, R. A. Rojer & J. B. Schnog

  3. Department of Internal Medicine, Slotervaart Hospital, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands

    M. R. Mac Gillavry, H. ten Cate, D. P. M. Brandjes & J. B. Schnog

Authors
  1. A. J. Duits
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. A. Rojer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. van Endt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. R. Mac Gillavry
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. ten Cate
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. P. M. Brandjes
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. B. Schnog
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. B. Schnog.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duits, A.J., Rojer, R.A., van Endt, T. et al. Erythropoiesis and serum sVCAM-1 levels in adults with sickle cell disease. Ann Hematol 82, 171–174 (2003). https://doi.org/10.1007/s00277-003-0610-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-003-0610-8

Keywords

Search

Navigation